The use of ninjin’yoeito in a COPD mouse model suppressed the loss of muscle mass and alteration in the muscle fiber distribution by increasing expression of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha, which is involved in skeletal muscle function [36]. This evidence concerns the gene PPARGC1A and chronic obstructive pulmonary disease.